PDK LABS INC
NT 10-Q, 1998-07-14
PHARMACEUTICAL PREPARATIONS
Previous: INTEGRATED SILICON SOLUTION INC, 8-K, 1998-07-14
Next: TURKISH INVESTMENT FUND INC, NSAR-A, 1998-07-14




<PAGE>

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  FORM 12b-25

                          NOTIFICATION OF LATE FILING

(Check one)

[ ] Form 10-K and Form 10-KSB  [ ] Form 20-F  [ ] Form 11-K  [X] Form 10-Q and
Form 10-QSB  [ ] Form N-SAR

                  For Period Ended May 31, 1998

                  __ Transition Report on Form 10-K and Form 10-KSB
                  __ Transition Report on Form 20-F
                  __ Transition Report on Form 11-K
                  __ Transition Report on Form 10-Q and Form 10-QSB
                  __ Transition Report on Form N-SAR
                  For the Transition Period Ended: _____________

Read Instructions (on back page) Before Preparing Form,  Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates: ______________________________

PART I--REGISTRANT INFORMATION

Full Name of Registrant: PDK LABS INC.

Former Name of Registrant: _____________________

Address of Principal Executive Office (Street and Number):

145 Ricefield Lane, Hauppauge, NY  11788

<PAGE>

PART II--RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25b, the
following should be completed. (Check box if appropriate): [X]

          (a)  The reasons described in reasonable detail in Part III of this
               form could not be eliminated without unreasonable effort or
               expenses;

          (b)  The subject annual report, semi-annual report, transition
               report on Forms 10-K, 10-KSB, Form 20-F, 11-K, Form N-SAR, or
               portion thereof, will be filed on or before the fifteenth
               calendar day following the prescribed due date; or the subject
               quarterly report or transition report on Forms 10-Q, 10-QSB, or
               portion thereof will be filed on or before the fifth calendar
               day following the prescribed due date; and

          (c)  The accountant's statement or other exhibit required by Rule
               12b-25(c) has been attached if applicable.

PART III--NARRATIVE

State below in reasonable detail the reasons why the Forms 10-K, 10-KSB, 20-F,
11-K, 10-Q,10-QSB, N-SAR, or the transition report or portion thereof, could
not be filed within the prescribed time period. (Attach Extra Sheets if
Needed)

         The Company has not been able to finalize the financial statements for
the Company's Quarterly Report on Form 10-Q by July 15, 1998, the required
filing date, without unreasonable effort.

PART IV--OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
     notification

  Michael B. Krasnoff             (516)                     273-2630
  -------------------             -----                     --------
         (Name)                (Area Code)             (Telephone Number)

(2)  Have all other periodic reports required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company
     Act of 1940 during the preceding 12 months (or for such shorter period
     that the registrant was required to file such reports) been filed? If
     answer is no, identify report(s).  [X] Yes  [ ] No

(3)  Is it anticipated that any significant change in results of operations
     from the corresponding period for the last fiscal year will be reflected
     by the earnings statements to be included in the subject report or
     portion thereof?  [ ] Yes  [X] No

     If so, attach an explanation of the anticipated change, both narratively
     and quantitatively, and, if appropriate, state the reasons why a
     reasonable estimate of the results cannot be made.


<PAGE>

                                 PDK LABS INC.
                                 -------------
                 (Name of Registrant as Specified In Charter)

has caused this notification to be signed on its behalf by the undersigned
hereto duly authorized

Dated: July 15, 1998                      PDK LABS INC.


                                       By:/s/ MICHAEL B. KRASNOFF
                                          ------------------------------
                                          Michael B. Krasnoff, President


INSTRUCTION: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the
person signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representatives's authority
to sign on behalf of the registrant shall be filed with the form.

                                   ATTENTION
         Intention misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).

                             GENERAL INSTRUCTIONS

1.   This form is required by Rule 12b-25 (17 CFR 240.12b-25 of the General
     Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed original and four conformed copies of this form and amendments
     thereto must be completed and filed with the Securities and Exchange
     Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
     General Rules and Regulations under the Act. The information contained in
     or filed with the form will be made a matter of public record in the
     Commission files.

3.   A manually signed copy of the form and amendments thereto shall be filed
     with each national securities exchange on which any class of securities
     of the registrant is registered.

4.   Amendments to the notifications must also be filed on form 12b-25 but
     need not restate information that has been correctly furnished. The form
     shall be clearly identified as an amendment notification.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission